Three different hTERT-immortalized human primary renal proximal tubule epithelial cells (RPTEC) were modified and tested for functionality and stable expression of the OAT1, OCT2, and OAT3 proteins.

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC ... baseline renal insufficiency, and significant comorbid ...

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Kidney Cancer (Renal Cell Cancer).